Eszopiclone in the treatment of insomnia and associated symptoms of fibromyalgia

Trial Profile

Eszopiclone in the treatment of insomnia and associated symptoms of fibromyalgia

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Apr 2014

At a glance

  • Drugs Eszopiclone (Primary)
  • Indications Fibromyalgia; Insomnia
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Feb 2010 Actual end date (1 Mar 2009) added as reported by ClinicalTrials.gov record.
    • 09 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 09 Jun 2008 The expected completion date for this trial is now 1 Jan 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top